Drug Shortage Report for NAT-LEVETIRACETAM
| Report ID | 64878 |
| Drug Identification Number | 02440210 |
| Brand name | NAT-LEVETIRACETAM |
| Common or Proper name | LEVETIRACETAM Tablets |
| Company Name | NATCO PHARMA (CANADA) INC |
| Market Status | MARKETED |
| Active Ingredient(s) | LEVETIRACETAM |
| Strength(s) | 500MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 120 |
| ATC code | N03AX |
| ATC description | ANTIEPILEPTICS |
| Reason for shortage | Requirements related to complying with good manufacturing practices. |
| Anticipated start date | 2018-09-26 |
| Actual start date | 2018-09-26 |
| Estimated end date | Unknown |
| Actual end date | 2020-10-08 |
| Shortage status | Resolved |
| Updated date | 2020-10-26 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2000 ARGENTIA ROAD, PLAZA 1, SUITE 200 MISSISSAUGA, ONTARIO CANADA L5N 1P7 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v21 | 2019-04-17 | English | Compare |
| v22 | 2019-04-17 | French | Compare |
| v23 | 2020-10-26 | English | Compare |
| v24 | 2020-10-26 | French | Compare |